{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:50:38Z","timestamp":1786719038264,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijo.ijo_1352_18","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:18:15Z","timestamp":1555978695000},"page":"594","source":"Crossref","is-referenced-by-count":21,"title":["Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis"],"prefix":"10.4103","volume":"67","author":[{"given":"Rahul","family":"Bhargava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.256663-1","first-page":"1661","volume-title":"Virology, and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953-2013","author":"Zhang","year":"2016","journal-title":"Epidemiol Infect"},{"key":"key-10.4103\/0301-4738.256663-2","first-page":"435","volume-title":"Adenoviral keratoconjunctivitis","author":"Jhanji","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.256663-3","first-page":"917","volume-title":"The clinical features of viral keratitis and a concept of their pathogenesis","author":"Jones","year":"1958","journal-title":"Proc R Soc Med"},{"key":"key-10.4103\/0301-4738.256663-4","first-page":"e1000841","volume-title":"Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis","author":"Chintakuntlawar","year":"2010","journal-title":"PLoS Pathog"},{"key":"key-10.4103\/0301-4738.256663-5","first-page":"477","volume-title":"Human adenovirus type 8: The major agent of epidemic keratoconjunctivitis (EKC)","author":"Adhikary","year":"2014","journal-title":"J Clin Virol"},{"key":"key-10.4103\/0301-4738.256663-6","first-page":"289","volume-title":"Topical corticosteroids of limited potency promote adenovirus replication in the Ad5\/NZW rabbit ocular model","author":"Romanowski","year":"2002","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.256663-7","first-page":"781","volume-title":"Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis","author":"Asena","year":"2017","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.256663-8","first-page":"657","volume-title":"Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand white rabbit","author":"Romanowski","year":"2001","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.256663-9","first-page":"638","volume-title":"Topical treatment with 1% cyclosporine for sub epithelial infiltrates secondary to adenoviral keratoconjunctivitis","author":"Levinger","year":"2010","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.256663-10","first-page":"228","volume-title":"Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis","author":"Kymionis","year":"2008","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.256663-11","first-page":"417","volume-title":"Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders","author":"Joseph","year":"2005","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.256663-12","first-page":"413","volume-title":"Oral omega-3 fatty acid treatment for dry eye in contact lens wearers","author":"Bhargava","year":"2015","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.256663-13","first-page":"S1","volume-title":"Adenovirus ocular infections prevalence, pathology, pitfalls, and practical pointers","author":"Garcia-Zalisnak","year":"2018","journal-title":"Eye Contact Lens"},{"key":"key-10.4103\/0301-4738.256663-14","first-page":"172","volume-title":"Antiviral therapy for adenovirus infections","author":"Lenaerts","year":"2006","journal-title":"Antiviral Res"},{"key":"key-10.4103\/0301-4738.256663-15","first-page":"1487","volume-title":"Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: A controlled clinical pilot study","author":"Hillenkamp","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.256663-16","first-page":"634","volume-title":"Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis","author":"Muftuoglu","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"key-10.4103\/0301-4738.256663-17","first-page":"1210","volume-title":"Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis","author":"Ghanem","year":"2014","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.256663-18","first-page":"811","volume-title":"Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis","author":"Levinger","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.256663-19","first-page":"649","volume-title":"Symptomatic treatment of subepithelial infiltrates after viral conjunctivitis: Loteprednol or dexamethasone?","author":"Ko\u00e7luk","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.256663-20","first-page":"1102","volume-title":"Topical tacrolimus for corneal subepithelial infiltrates secondary to adenoviral keratoconjunctivitis","author":"Berisa","year":"2017","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.256663-21","first-page":"42","volume-title":"Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis","author":"Okumus","year":"2012","journal-title":"BMC Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:43:05Z","timestamp":1786714985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1352_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"alternative-id":["256663"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1352_18","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}